Vitiligo
RecruitingStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
- Disease:Vitiligo
- Substances:Ruxolitinib
Hungary- Participants:0–17 years
- Substances:Ruxolitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
Back to Hungary1 045 clinical trials in Budapest, Hungary across 10 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
HungaryThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for inflammatory disorders, including studies on new therapies for psoriasis, psoriatic arthritis, and chronic urticaria.
Multiple clinical trials are investigating targeted therapies and their long-term effectiveness in managing inflammatory conditions.
Studies centered on preventing and treating various infections, with particular emphasis on meningococcal vaccines and respiratory conditions.
Research includes both preventive vaccines and therapeutic approaches for various infectious diseases.
Comprehensive research into heart failure prevention and management of chronic conditions, including studies on kidney disease and obesity.
Investigations focus on innovative therapeutic combinations and their impact on cardiovascular outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.